Technology Investment for Advanced Therapies: Investing in the Future

20 Jan 2023
Commercializing the Therapies of the Future Track

11:00am Chair Introduction

Julie Lenzer, Chief Innovation Officer, Advanced Regenerative Manufacturing Institute (ARMI)


11:05am Presentation: Secrets in the Pitch – Lessons Learned in Fund-Raising in Cell & Gene Therapy

• What do investors really want to hear, and more importantly
• What do you think they want to hear – but they really don’t

Bryan Poltilove, Operating Partner, BroadOak Capital Partners & Xavier de Mollerat du Jeu, Senior Director R&D, Thermo Fisher Scientific


11:20am Presentation: Latest Innovative Technologies and Investments in Immuno-oncology

  • iPS cells
  • Cloaking/hypoimmunogenic cells
  • In vivo CAR-T

Stefanos Theoharis, Core Team Member, Cell One Partners


11:35am Closing Panel with Q&A

Joined by Jacob Becraft, CEO, Strand Therapeutics


Bryan Poltilove
Operating Partner
Broadoak Capital Partners
Jacob Becraft
Co-Founder & CEO
Strand Therapeutics
Julie Lenzer
Chief Innovation Officer
Stefanos Theoharis
Core Team Member
Cell One Partners
Xavier De Mollerat Du Jeu
Senior Director of Research and Development
Thermo Fisher Scientific Inc